Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • ScienceGrrl
    Junior Member
    • Jul 2015
    • 8

    #16
    Hello Arthur45,

    Make sure you have a very accurate quant of your input samples. Nextera is a mass driven setup so if you are off on your initial quant at all, can get results of too large/too small fragments very easily.

    Comment

    • Simone78
      Senior Member
      • Oct 2010
      • 208

      #17
      hi Arthur 45,
      sorry for the misunderstanding. You do need to clean up the cDNA after the first PCR (pre-amplification for the Smart-seq2 protocol). I am not really familiar with the latest version of the Nextera protocol but the 30 + 30 ul beads sounds a bit strange to me.
      I know that Nextera is using the Zymo and Nextera XT is not. We decided to not use a column purifcation because it´s cheap and equally effective.
      That said, I am not sure what you have there. A single fragment at 1 kb doesn´t look like a standard library (is it a ladder or similar?). Why don´t you just take some tot RNA , let´s say 1 ng, do some pre-ampl and try to tagment that? I agree that the Tape after tagmentation has no library. Don´t really know why, though

      Comment

      • Arthur45
        Junior Member
        • May 2017
        • 7

        #18
        Hi both,

        thanks for your answers

        About the 30+30 ul steps: I called Illumina since and the representative agreed that this *might* be a typo. He raised an issue for their protocol team. This team will change the protocol when the next version of the protocol will be out.

        About my graphs: the graph with the 1kb peaks is my DNA before starting the library. The other graph is right after the tagmentation. It looks like there is no more DNA after tagmentation. I am starting to think that my input is not of the right concentration like ScienceGrrl said. And also, I read somewhere that DNA should be clean before starting a library, so I will try to clean my phenol-chloroform extractions with a spin column, just in case.

        Cheers,
        arthur

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          Yesterday, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:10 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        39 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...